Reporting of Human Adenoviruses Has Declined Since COVID-19

Follow Drugslib on

Medically reviewed by Carmen Pope, BPharm. Last updated on Dec 27, 2024.

By Elana Gotkine HealthDay Reporter

FRIDAY, Dec. 27, 2024 -- Reporting of human adenovirus (HAdV) types decreased since the COVID-19 pandemic, according to research published in the Dec. 19 issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.

Fatima Abdirizak, M.P.H., from the CDC in Atlanta, and colleagues summarized the distribution of HAdV types reported to the National Adenovirus Type Reporting System during 2017 to 2023.

The researchers found that 2,241 HAdV specimens with typing results were reported during the seven-year period. During 2017 to 2019, the number of specimens with HAdV typing results reported varied annually (range, 389 to 562) and decreased during 2020 to 2023 (range, 58 to 356). Six HAdV types (1 to 4, 7, and 14) accounted for 88.3 percent of typed specimens reported during 2017 to 2023; overall, 17.0 percent of specimens were outbreak-related. During 2021 to 2022, an increase in type 41 reporting was associated with a hepatitis cluster. Since the COVID-19 pandemic, there was a decrease seen in reporting to the National Adenovirus Type Reporting System, despite continued HAdV circulation reported through passive laboratory surveillance.

"Expanded laboratory capacity to type HAdVs and enhanced reporting could improve national understanding of HAdV circulation patterns and better guide public health prevention strategies," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

Source: HealthDay

Posted : 2024-12-28 06:00

Read more

Disclaimer

Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.

The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Popular Keywords